Results 51 to 60 of about 48,920 (196)

Hearing Loss and Middle Ear Effusion in Nasopharyngeal Carcinoma Following Radiotherapy: Dose–Response Relationship and Normal Tissue Complication Probability Modeling

open access: yesInternational Archives of Otorhinolaryngology
Introduction Radiotherapy is the primary treatment for nasopharyngeal carcinoma. Radiation exposure to the cochlea and middle ear can cause hearing loss.
Prem Wungcharoen   +2 more
doaj   +1 more source

Actinomycosis Imitating Nasopharyngeal Carcinoma

open access: yes, 2009
The incidence of nasopharyngeal actinomycosis is exceedingly rare. To our knowledge, only 1 case has been reported previously. This article presents 4 cases of actinomycosis involving the nasopharynx that imitated nasopharyngeal carcinoma.
張雅玲;婁培人   +1 more
core  

Thyroid-Like Low-Grade Nasopharyngeal Papillary Adenocarcinoma with Biphasic Histology

open access: yes, 2020
Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma (TL-LGNPPA) is a rare primary adenocarcinoma of nasopharynx. The immunohistochemical pattern of this tumor is similar to that of papillary thyroid carcinoma making this neoplasm a challenging
Nestor Dela Cruz   +2 more
core   +1 more source

Hamartomas of the oro- and nasopharyngeal cavity in infancy: two cases and a short review

open access: yes, 2009
Introduction Oro- and nasopharyngeal masses are rare in infancy and consist of developmental anomalies and, mostly benign, neoplasms. Case report We report two infants with a tumour in the ear-nose-throat region.
Hulsmann, AR   +3 more
core   +1 more source

Die Bedeutung von Epstein-Barr-Virus-Antikörpern für Diagnose und Verlauf des Nasopharynxkarzinoms = Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl.) [PDF]

open access: yes, 1979
Sera collected from patients with nasopharyngeal carcinoma, patients with other head and neck neoplasms, patients with infectious mononucleosis (IM), and healthy donors were titrated for antibodies (IgM, IgG, IgA) against Epstein-Barr-Virus (EBV ...
Wilmes, E.   +3 more
core   +1 more source

Time Dependence of Radiation-induced Hypothalamic-Pituitary Axis Dysfunction in Adults Treated for Non-pituitary, Intracranial Neoplasms

open access: yes, 2017
AIMS: Hypothalamic-pituitary axis (HPA) dysfunction is a sequela of cranial radiotherapy. The purpose of this study was to use endocrine data from existing publications to characterise the baseline endocrine status, the effects of radiotherapy on the HPA
Jena, R, Burnet, N, Taku, N, Gurnell, M
core   +1 more source

Mortality from lymphohematopoietic neoplasms and other causes in a cohort of laminated plastic workers exposed to formaldehyde [PDF]

open access: yes, 2014
Purpose A possible relationship between exposure to formaldehyde and leukemia-particularly myeloid leukemia-as well as of lymphoid neoplasms has been debated and is still controversial.
F. Verga   +3 more
core   +1 more source

Experiencia en el tratamiento quirúrgico del angiofibroma nasal juvenil en Hospital de Especialidades No 2 Lic. Luis Donaldo Colosio Murrieta. Instituto Mexicano del Seguro Social de Ciudad Obregón, Sonora

open access: yesHorizonte Médico, 2018
Objective: To present our experience and assess the recurrence of juvenile nasopharyngeal angiofibroma after a surgical treatment (open versus endoscopic approach) in the country’s northwestern Department of Otorhinolaryngology.
Rubio-Espinoza A   +4 more
doaj   +1 more source

Walsh & Hoyt: Nasopharyngeal Carcinomas

open access: yes, 2005
Malignant carcinomas originating within the nasopharynx are rare. In North America, they constitute only about 0.25% of all cancers, and their incidence is about 5 per 1,000,000.
Benjamin M. Frishberg, MD
core  

An alternative way to perform diagnostic nasopharyngeal swab for SARS-CoV-2 infection

open access: yes, 2020
On March 11, 2020, WHO has defined the novel coronavirus disease SARS-CoV-2 (COVID-19) outbreak as a pandemic and still today continues to affect much of the world.
Spinozzi, Giuseppe   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy